All 1 tracked stories fall under one category: market-trends. Baxter is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 5.9. They are corroborated in line with the beat average, carrying 3 original sources each against 3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Synchrony Financial
All 1 tracked stories fall under one category: market-trends. Baxter is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 5.9. They are corroborated in line with the beat average, carrying 3 original sources each against 3 for the same window. Synchrony Financial appears in 1 tracked Healthcare story from March 19, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Synchrony Financial. Shared-story counts are live from our verified record — not editorial picks.
Recent stock performance comparisons for Baxter and Synchrony Financial highlight a diverging landscape between medical device manufacturing and healthcare consumer financing. While Baxter navigates portfolio optimization, Synchrony's CareCredit remains a critical indicator of consumer spending on elective health services.
Synchrony Financial is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.